The mRNA “vaccines” produced by Big Pharma might as well have been made from carpet sweepings and industrial waste, as far as the European Medicines Agency was concerned. It didn’t matter what was in them — given that the “pandemic” had been declared an emergency, something had to be done, and the fact that it was an emergency meant any and all means would be justified.

Now it appears that the EMA intends to end the emergency use authorization and approve the vax for standard use, without ever acquiring or evaluating any data on long-term safety.

Many thanks to Hellequin GB for translating this article from Boris Reitschuster’s website. The translator’s comments are in square brackets.

EMA announces standard approval for BioNTech and Moderna

European Medicines Agency exposes itself in the justification

by Kai Rebman

It was ultimately just a matter of time. After large portions of politicians and the media are already acting as if the mRNA products from BioNTech and Moderna are regularly approved “vaccines”, they will soon be officially granted this status. The EMA’s Committee for Medicinal Products for Human Use (CHMP) has now recommended converting the conditional authorizations for the “marketing of the Covid-19 vaccines Comirnaty (BioNTech) and Spikevax (Moderna) into standard authorisations”. The annual renewal of approvals that was previously required would then no longer apply, but all other obligations on the part of the companies would remain in place, as the EMA asserts. The letter does not state which obligations these should be, especially since the manufacturers have already had themselves indemnified in good time from almost all liability.

After that, the way the conditional admission came about can only be described as scandalous. The EMA has now explained once again how it happened from their point of view. According to this, the conditional approval was granted at the time because, firstly, a “positive risk-benefit ratio” was assumed and, secondly, the products addressed an “unmet medical need” and were used in the event of an “emergency, as should, in the public health sector”. Third and lastly, EMA considered it “likely” that the applicants would be able to provide more comprehensive, post-authorisation, clinical and high-quality data, which it considers necessary, given the novel mode of action of the vaccines and their expected very wide use.”

In other words: At the time the conditional approval was granted, these “clinical and high-quality data” were not available; it was only assumed that it would “probably” be submitted at some point. In practice, however, people were usually satisfied if the manufacturers, for example, used the results of presented “studies” with eight MICE. What is good for eight mice cannot be bad for millions of people, seems to have been the thought at the EMA, among others.

EMA spreads misinformation and admits medical experiment

According to the EMA, these and other studies are said to have provided “reassuring data”[if your aim is mass-murder], which are said to prove that the “vaccines” are capable of preventing serious illnesses. [LOL, LOL, LOL… rolling on the carpet, while fighting for breath to laugh some more. CYNICALLY.] In addition, the companies submitted all requested “additional data on the pharmaceutical quality of the vaccines.” The EMA once again did not want to reveal what data these are. [I can imagine.] It also remained unclear which studies are intended to support the above assertion in relation to the severe course of the disease. The EMA demonstrably has completely different prior data.

Regardless, the European Medicines Agency is spreading even more misinformation. Taking into account “all available data”, the “vaccines” are classified as “effective and safe” [for mass depopulation]. In contrast to the examples mentioned above, the EMA in this context provides at least an indication of how it came to this bold thesis.

According to the EMA, these data on the efficacy and safety have resulted “from the widespread use of these vaccines”. It is believed to have been misread, but the fact is that because “clinical and high-quality data” were not available at the time the conditional approval was granted, these data were collected as part of a field trial unprecedented in the history of medicine. It is no different when the EMA writes here about the “broad use of these vaccines” and the data obtained from them. What is almost even more astonishing, however, is how the EMA can come to the conclusion that the “vaccines” are effective and safe when evaluating this very data. This shows either a high degree of denial of reality or blind adherence to a given agenda — or both. [Just follow the money and you’ll know the “WHY”. It’s that simple.]

Protecting manufacturers is more important than protecting people

In general, the EMA sees a positive risk-benefit ratio of the “products” (quote EMA) as proven, which is why they decided to get away from conditional approval and clear the way for standard approval. On the other hand, every village doctor will be able to confirm that the assessment of this risk-benefit ratio is a very individual assessment that depends on many factors and must therefore be checked for each patient on a case-by-case basis. The EMA also makes no secret of the fact that they are giving manufacturers a free pass for all time by switching to a standard approval. The notice states: “This recommendation applies to all existing and upcoming adapted Comirnaty and Spikevax vaccines, including the recently approved adapted Comirnaty Original/Omicron BA.1, Comirnaty Original/Omicron BA.4/5 and Spikevax bivalent Original/ Omicron BA.1.”

In connection with the highly praised bivalency of the “vaccines”, one question has hardly been asked: Why are there still ingredients in the current vaccines that are supposed to work against the Wuhan strain or the Delta variant? At the end of the letter , the EMA affirms that it also wants to “continue to monitor closely” Comirnaty and Spikevax. Any new data would be evaluated immediately as it becomes available, with a view to taking “measures to protect patients” [yeah, right] if necessary. However, the way the EMA has acted in connection with the “vaccines” over the past two years has given the impression that it is more concerned, and first and foremost, with protecting the manufacturers [and their own investment portfolios].

Afterword from the translator:

Two out of eight mice died almost immediately. That means that by roughly eight billion humans, two billion will die from the Mengele-juice almost immediately. Sounds about right from what we’ve seen so far, and everything is going according to PLAN. At least six of them survived the vaccination. Whether with or without vaccination damage is not known. Nothing at all about possible late side effects. Whether the vaccination also protects against the virus will only become apparent when the surviving six mice have become infected… We don’t yet know what will happen to the remaining “six” billion. In any case, the experiences of the last two years do not promise anything good for the peasant class.